News

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...
The U.S. Food and Drug Administration has approved Vizz 1.44% (aceclidine ophthalmic solution) for the treatment of ...
The University of Bath, in partnership with the University of Edinburgh, has conducted the most extensive growth and ...
The Health and Human Services secretary said he is reviewing whether to remove the medical experts on the U.S. Preventive Services Task Force who advise on cancer screenings, HIV prevention drugs, and ...